Layla (PG201) / PMG Pharm, Helixmith 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  Layla (PG201) / PMG Pharm
    [VIRTUAL] Developing an inclusive department culture: Experiences from a pilot anti-racism workshop at Portland State University () -  Mar 28, 2021 - Abstract #ACSSp2021ACS-Sp_4052;    
    The ten-week long workshop centered around Layla F. Saad’s Me and White Supremacy, and used the reflection activities as a springboard for group discussions...Information on the resources and effort needed to begin similar projects in other departments will be provided. This workshop is now in its second iteration, and we hope to encourage similar projects in other STEM departments to create a more inclusive scientific culture.
  • ||||||||||  Layla (PG201) / PMG Pharm
    Oh Layla!!!!! (Twitter) -  Dec 13, 2020   
  • ||||||||||  Layla (PG201) / PMG Pharm
    Journal:  Characterization of a New Rhamnolipid Biosurfactant Complex from Pseudomonas Isolate DYNA270. (Pubmed Central) -  Sep 19, 2020   
    The pH optimum, critical micelle concentration, and effective alkane carbon number were established for Pseudomonas species DYNA270 and compared to those of rhamnolipid produced by Pseudomonas aeruginosa PG201...Similar CMC values of 20 mg/L have been reported for rhamnolipids, a few being recorded as 5-10 mg/L for Pseudomonas species DSM2874 (Lang et al. 1984).
  • ||||||||||  Layla (PG201) / PMG Pharm
    Layla (Twitter) -  Mar 30, 2020   
  • ||||||||||  Layla (PG201) / PMG Pharm
    Layla. (Twitter) -  Mar 30, 2020   
  • ||||||||||  Layla (PG201) / PMG Pharm
    Clinical, Journal:  Comics and revolution as global public health intervention: The Case of Lissa. (Pubmed Central) -  Oct 25, 2019   
    Lissa also draws on ethnographic research and interviews in the U.S. on a seemingly unrelated topic - the social and political calculus of managing genetic risk for breast and ovarian cancer within a commercial healthcare system. We draw out the similarities in bioethical dilemmas between these two disparate clinical realities by composing an unlikely friendship between two fictional characters: Anna, the daughter of an American oil company executive living in Cairo, who has a family history of breast cancer - and Layla, the daughter of the porter of Anna's apartment building, who grows to become a resolute physician struggling for better public health justice and rights in Egypt.
  • ||||||||||  Trial completion, Trial primary completion date:  To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee (clinicaltrials.gov) -  Sep 19, 2017   
    P4,  N=134, Completed, 
    We draw out the similarities in bioethical dilemmas between these two disparate clinical realities by composing an unlikely friendship between two fictional characters: Anna, the daughter of an American oil company executive living in Cairo, who has a family history of breast cancer - and Layla, the daughter of the porter of Anna's apartment building, who grows to become a resolute physician struggling for better public health justice and rights in Egypt. Recruiting --> Completed | Trial primary completion date: Dec 2014 --> May 2015